Vanguard Global Advisers »

Acelrx Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $22k 30k 0.75

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Acelrx Pharmaceuticals

AIGH Capital Management
Rock Springs Capital Management
Rosalind Advisors
Nantahala Capital Management
Cantor Fitzgerald, L. P.
Bleichroeder
Caption Management
Vanguard Group
Empery Asset Management
Dauntless Investment Group
Almitas Capital
Vanguard Capital Management
Geode Capital Management
Susquehanna International
Renaissance Technologies

View all funds holding Acelrx Pharmaceuticals